Patient preferences for curettage followed by imiquimod 5% cream vs. surgical excision for the treatment of non-facial nodular basal cell carcinoma: a discrete choice experiment.

to evaluate patient preferences for the treatment of non-facial nodular basal cell carcinoma (nBCC) a discrete choice experiment (DCE) was performed alongside a clinical trial that compared curettage followed by imiquimod 5% cream and surgical excision.(1) The attributes used to describe the treatment options were: effectiveness (2-8), cosmetic outcome)(3), waiting time and side effects (3). (Table 1).